Drugs: respiratory system

Citations 1-10 of 66 total displayed.

Therapeutics
Review: inhaled corticosteroids do not reduce mortality but increase pneumonia in COPD

P John Rees
Evid. Based Med. 2009; 14: 74. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Oral prednisolone did not improve outcomes in preschool children with an attack of wheezing

Inge Axelsson
Evid. Based Med. 2009; 14: 77. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: formoterol increases serious adverse events in children and adults with chronic asthma

Jay Peters
Evid. Based Med. 2009; 14: 78. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
5-day and 3-day oral prednisolone did not differ for asthma control in children who had acute asthma exacerbations

Peter C Wyer
Evid. Based Med. 2009; 14: 40. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: inhaled anticholinergics increase risk of major cardiovascular events in COPD

Matthew B Stanbrook
Evid. Based Med. 2009; 14: 42-43. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: medication adjustment based on fractional exhaled nitric oxide did not prevent asthma exacerbations

Brian Smith, Jason D'Costa
Evid. Based Med. 2009; 14: 8. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: daily salmeterol increases non-fatal serious adverse events in chronic asthma

P John Rees
Evid. Based Med. 2009; 14: 14. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Dexamethasone and placebo did not differ for respiratory status change or hospital admission in infants with acute bronchiolitis

Terry P Klassen, Amy C Plint
Evid. Based Med. 2008; 13: 114. [Extract] [Full text] [PDF] [Request Permissions]  

Therapeutics
Review: corticosteroids plus LABAs reduce exacerbations and mortality more than steroids alone in COPD

Shirin Shafazand
Evid. Based Med. 2008; 13: 74. [Extract] [Full text] [PDF] [Request Permissions] [ web only appendix ]  

Therapeutics
Review: corticosteroids plus long-acting β-agonists reduce exacerbations more than long-acting β-agonists alone in COPD

Evid. Based Med. 2008; 13: 57. [Extract] [Full text] [PDF] [Request Permissions]